018653121

Nanomab

---

February 13, 2022

Trademark Summary

The trademark application Nanomab was filed by SHAPERON Inc., a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on June 12, 2022, and still open for oppositions.

The application was filed in English (Spanish was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Biological preparations for medical or veterinary purposes
  2. Biochemical preparations for medical or veterinary purposes
  3. Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
  4. Pharmaceuticals featuring drug delivery system
  5. Preparations for intracellular drug delivery
  6. Pharmaceuticals for the treatment of immune system disease
  7. Pharmaceutical preparations for the treatment of cancer
  8. Pharmaceutical preparations for the treatment of inflammatory diseases
  9. Pharmaceutical preparations for the treatment of immune system related diseases and disorders
  10. Pharmaceutical preparations for the treatment of cells
  11. Chemico-pharmaceutical preparations
  12. Protein preparations
  13. Biotechnological preparations for medical purposes
  14. Reagents for medical use
  15. Pharmaceuticals for human purposes
  16. Biochemical pharmaceuticals
  17. Biological tissue cultures for medical purposes
  18. Drug delivery agents
  19. Diagnostic reagents for medical use
  20. Pharmaceuticals.